Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …

…, N Jacobsen, W Arcese, P Ljungman, A Ferrant… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …

Super-resolution microscopy demystified

L Schermelleh, A Ferrand, T Huser, C Eggeling… - Nature cell …, 2019 - nature.com
Super-resolution microscopy (SRM) bypasses the diffraction limit, a physical barrier that restricts
the optical resolution to roughly 250 nm and was previously thought to be impenetrable. …

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

…, MA Boogaerts, HMS Demuynck, A Ferrant… - The Lancet, 1996 - Elsevier
Background A randomised trial comparing filgrastim-mobilised peripheral blood progenitor
cell (PBPC) transplants with autologous bone marrow transplantation (ABMT) for …

[HTML][HTML] High-dose daunorubicin in older patients with acute myeloid leukemia

…, HC Schouten, C Graux, A Ferrant… - … England Journal of …, 2009 - Mass Medical Soc
Background A complete remission is essential for prolonging survival in patients with acute
myeloid leukemia (AML). Daunorubicin is a cornerstone of the induction regimen, but the …

Magnetic resonance imaging of the bone marrow in hematological malignancies

BC Vande Berg, FE Lecouvet, L Michaux, A Ferrant… - European …, 1998 - Springer
Despite its lack of specificity, magnetic resonance imaging (MRI) of the bone marrow has the
potential to play a role in the management of patients with primary neoplastic disorders of …

[HTML][HTML] Cytarabine dose for acute myeloid leukemia

…, HC Schouten, C Graux, A Ferrant… - … England Journal of …, 2011 - Mass Medical Soc
Background Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia
(AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) …

[HTML][HTML] Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

…, H Schouten, G de Greef, A Ferrant… - … England Journal of …, 2003 - Mass Medical Soc
Background Sensitization of leukemic cells with hematopoietic growth factors may enhance
the cytotoxicity of chemotherapy in acute myeloid leukemia (AML). Methods In a multicenter …

Bacteraemia in febrile neutropenic cancer patients

…, A Georgala, F Muanza, M Aoun, A Ferrant… - International journal of …, 2007 - Elsevier
A total of 2142 patients with febrile neutropenia resulting from cancer chemotherapy were
registered in two observational studies and followed prospectively in different institutions. …

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology

…, S Chinn, G Barosi, A Ferrant… - British journal of …, 1995 - Wiley Online Library
Four European centres provided height and weight data on 202 males and 204 females
undergoing red cell mass (RCM) and plasma volume (PV) measurements. For these populations…

Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium

…, A Ferster, B Brichard, J Ninane, A Ferrant… - Bone marrow …, 1998 - nature.com
Fifty patients affected by sickle cell anaemia underwent transplantation of HLA-identical
haematopoietic stem cells (bone marrow, 48; cord blood, 2). Two groups of patients were …